Amarin Corp Plcuk (AMRN) Return on Capital Employed (QoQ) (2011 - 2026)

Amarin Corp Plcuk (AMRN) Return on Capital Employed (QoQ) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 116.00
Dec 31, 2025 303.00
Sep 30, 2025 301.00
Jun 30, 2025 -353.00
Mar 31, 2025 -84.00
Dec 31, 2024 -534.00
Sep 30, 2024 -69.00
Jun 30, 2024 409.00
Mar 31, 2024 68.00
Dec 31, 2023 1,008.00
Sep 30, 2023 -290.00
Jun 30, 2023 558.00
Mar 31, 2023 151.00
Dec 31, 2022 -316.00
Sep 30, 2022 221.00
Jun 30, 2022 -1,230.00
Mar 31, 2022 -377.00
Dec 31, 2021 19.00
Sep 30, 2021 -96.00
Jun 30, 2021 72.00